Search research articles
Contact Us
Filters
Showing results (31-40 of 48) with videos related to
Page
of 5
Sort By:
The Journal of Infectious Diseases
|
September 22, 2021
Contrasting Epidemiology of Cholera in Bangladesh and Africa
David A Sack, Amanda K Debes, Jerome Ateudjieu, et al.
PLOS Global Public Health
|
May 21, 2026
Uganda's cholera elimination journey in a cholera endemic region of Africa
Godfrey Bwire, David A Sack, Allan Muruta, et al.
Plos One
|
March 24, 2016
A Comparison of the Adaptive Immune Response between Recovered Anthrax Patients and Individuals Receiving Three Different Anthrax Vaccines
Thomas R Laws, Tinatin Kuchuloria, Nazibriola Chitadze, et al.
BMC Infectious Diseases
|
June 15, 2021
Three transmission events of Vibrio cholerae O1 into Lusaka, Zambia
John Mwaba, Amanda K Debes, Kelsey N Murt, et al.
The American Journal of Tropical Medicine and Hygiene
|
November 17, 2022
An Age-stratified, Randomized Immunogenicity Trial of Killed Oral Cholera Vaccine with Delayed Second Dose in Cameroon
Jérôme Ateudjieu, David A Sack, Sonia Sonkeng Nafack, et al.
Pathogens (Basel, Switzerland)
|
December 31, 2025
Prevalence and Patterns of Enteric Co-Infections Among Individuals Presenting with Cholera-like Diarrheal Disease During Seasonal Cholera Outbreaks
Dhvani H Kuntawala, Samuel Bosomprah, Bernard Phiri, et al.
Medrxiv : the Preprint Server for Health Sciences
|
April 8, 2024
New <i>Vibrio cholerae</i> sequences from Eastern and Southern Africa alter our understanding of regional cholera transmission
Shaoming Xiao, Ahmed Abade, Waqo Boru, et al.
Plos One
|
December 20, 2016
Cholera Rapid Test with Enrichment Step Has Diagnostic Performance Equivalent to Culture
Lameck N Ontweka, Lul O Deng, Jean Rauzier, et al.
Vaccine
|
July 4, 2021
Serum vibriocidal responses when second doses of oral cholera vaccine are delayed 6 months in Zambia
John Mwaba, Caroline Cleopatra Chisenga, Shaoming Xiao, et al.
Frontiers in Immunology
|
November 29, 2023
Three doses of COVID-19 mRNA vaccine induce class-switched antibody responses in inflammatory arthritis patients on immunomodulatory therapies
Jenny M Lee, Alexis Figueroa, Jaiprasath Sachithanandham, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 48) with videos related to
Sort By:
Page
of 5
The Journal of Infectious Diseases
|
September 22, 2021
Contrasting Epidemiology of Cholera in Bangladesh and Africa
David A Sack, Amanda K Debes, Jerome Ateudjieu, et al.
PLOS Global Public Health
|
May 21, 2026
Uganda's cholera elimination journey in a cholera endemic region of Africa
Godfrey Bwire, David A Sack, Allan Muruta, et al.
Plos One
|
March 24, 2016
A Comparison of the Adaptive Immune Response between Recovered Anthrax Patients and Individuals Receiving Three Different Anthrax Vaccines
Thomas R Laws, Tinatin Kuchuloria, Nazibriola Chitadze, et al.
BMC Infectious Diseases
|
June 15, 2021
Three transmission events of Vibrio cholerae O1 into Lusaka, Zambia
John Mwaba, Amanda K Debes, Kelsey N Murt, et al.
The American Journal of Tropical Medicine and Hygiene
|
November 17, 2022
An Age-stratified, Randomized Immunogenicity Trial of Killed Oral Cholera Vaccine with Delayed Second Dose in Cameroon
Jérôme Ateudjieu, David A Sack, Sonia Sonkeng Nafack, et al.
Pathogens (Basel, Switzerland)
|
December 31, 2025
Prevalence and Patterns of Enteric Co-Infections Among Individuals Presenting with Cholera-like Diarrheal Disease During Seasonal Cholera Outbreaks
Dhvani H Kuntawala, Samuel Bosomprah, Bernard Phiri, et al.
Medrxiv : the Preprint Server for Health Sciences
|
April 8, 2024
New <i>Vibrio cholerae</i> sequences from Eastern and Southern Africa alter our understanding of regional cholera transmission
Shaoming Xiao, Ahmed Abade, Waqo Boru, et al.
Plos One
|
December 20, 2016
Cholera Rapid Test with Enrichment Step Has Diagnostic Performance Equivalent to Culture
Lameck N Ontweka, Lul O Deng, Jean Rauzier, et al.
Vaccine
|
July 4, 2021
Serum vibriocidal responses when second doses of oral cholera vaccine are delayed 6 months in Zambia
John Mwaba, Caroline Cleopatra Chisenga, Shaoming Xiao, et al.
Frontiers in Immunology
|
November 29, 2023
Three doses of COVID-19 mRNA vaccine induce class-switched antibody responses in inflammatory arthritis patients on immunomodulatory therapies
Jenny M Lee, Alexis Figueroa, Jaiprasath Sachithanandham, et al.
Page
of 5